Correct Answer: C. Phenoxybenzamine
Phenoxybenzamine is a non-selective, irreversible alpha-adrenergic antagonist that is the gold-standard preoperative preparation for pheochromocytoma surgery in India and globally. The discriminating principle: pheochromocytoma causes uncontrolled catecholamine release, leading to severe hypertension, arrhythmias, and myocardial infarction risk during surgical manipulation. Phenoxybenzamine blocks both α1 and α2 receptors irreversibly, preventing catecholamine-induced vasoconstriction and allowing blood volume expansion (which is depleted due to chronic vasoconstriction). It is given 7–10 days preoperatively at doses of 10–20 mg twice daily, titrated to achieve blood pressure control and orthostatic hypotension (a sign of adequate alpha blockade). Only after adequate alpha blockade is achieved should beta-blockers (like esmolol or propranolol) be added to control reflex tachycardia—never beta-blockers alone, as unopposed alpha stimulation causes hypertensive crisis. This two-step approach (alpha first, then beta) is mandated by AIIMS and major Indian surgical guidelines. Phenoxybenzamine's irreversible binding ensures sustained blockade even during the catecholamine surge of surgical manipulation, making it superior to reversible agents like doxazosin in the acute perioperative setting.
Why the other options are wrong
A. Aspirin — Aspirin is an antiplatelet and anti-inflammatory agent with no role in pheochromocytoma preoperative preparation. While anticoagulation may be considered in some high-risk cases, aspirin does not address the primary threat—catecholamine-induced hypertension and arrhythmias. This is an NBE distractor that tests whether students confuse perioperative thromboprophylaxis with catecholamine management. B. Clonidine — Clonidine is a central α2-agonist that lowers blood pressure by reducing sympathetic outflow, but it is contraindicated in pheochromocytoma. Sudden clonidine withdrawal causes rebound hypertension, and its use may paradoxically worsen catecholamine-mediated hypertension. The NBE trap: students may confuse clonidine (which lowers BP) with alpha-blockade, forgetting that pheochromocytoma requires peripheral alpha antagonism, not central sympathetic suppression. D. Esmolol — Esmolol is a short-acting beta-1 selective blocker used for intraoperative tachycardia control, but it is never given as monotherapy in pheochromocytoma preoperative preparation. Beta-blockade without prior alpha-blockade causes unopposed alpha-mediated vasoconstriction, triggering hypertensive crisis. Esmolol is only added after phenoxybenzamine achieves adequate alpha blockade. This is a classic NBE trap testing knowledge of the mandatory sequence: alpha first, beta second.
High-Yield Facts
- Phenoxybenzamine is the preoperative drug of choice for pheochromocytoma—irreversible, non-selective alpha antagonist given 7–10 days before surgery.
- Alpha-blockade first, beta-blockade second is the cardinal rule; beta-blockers alone cause hypertensive crisis due to unopposed alpha stimulation.
- Orthostatic hypotension during phenoxybenzamine therapy indicates adequate alpha blockade and blood volume expansion—a therapeutic endpoint.
- Catecholamine surge during surgical manipulation is the primary perioperative risk; phenoxybenzamine's irreversible binding prevents this surge.
- Doxazosin (reversible alpha-1 antagonist) is used for chronic outpatient management but is inferior to phenoxybenzamine for acute preoperative preparation.
Mnemonics
ALPHA FIRST, BETA SECOND In pheochromocytoma preop: (A)lpha-blocker first (phenoxybenzamine) → (B)eta-blocker second (propranolol/esmolol). Never reverse the order. Use when deciding preop drug sequence for pheo. PHENo = PHEochromocytoma PHEnoxybenzamine for PHEochromocytoma—the 'PHE' sound links the drug to the disease. Irreversible alpha antagonist, given preoperatively. Quick recall tool for exam hall.
NBE Trap
NBE pairs pheochromocytoma with beta-blockers (esmolol) to lure students who know "beta-blockers control tachycardia" but forget the mandatory alpha-blockade-first rule. The trap tests whether students understand the sequence of drug administration, not just individual drug actions.
Clinical Pearl
In Indian tertiary centres (AIIMS, CMC Vellore), preoperative phenoxybenzamine is non-negotiable for pheochromocytoma surgery. Patients often present with uncontrolled hypertension and tachycardia; phenoxybenzamine converts them to a "safe" surgical state within 7–10 days. Orthostatic hypotension (patient cannot stand without dizziness) is the clinical sign that alpha blockade is adequate and surgery can proceed safely.
_Reference: Bailey & Love Ch. 40 (Endocrine Surgery); Harrison Ch. 405 (Pheochromocytoma); KD Tripathi Ch. 12 (Adrenergic Antagonists)_